Popular Articles

Encouraging People To Sit Less And Eat Better Through Workplace E-Mail Intervention Program
An e-mail intervention program is an effective way to significantly improve diet and physical activity by helping people move more, sit less, and make healthier food choices, according to a Kaiser Permanente Division of Research study in the American Journal of Preventive Medicine.
generic viagra
Merz Pharmaceuticals Announce Three Studies Of NT-201 - (Botulinum Neurotoxin Type A Free From Complexing Proteins)
Results from three placebo controlled studies conducted to assess NT-201 in upper limb post-stroke spasticity, pre-treated cervical dystonia, and treatment-naive cervical dystonia patients represent the second data set presented at the Movement Disorder Society (MDS) 13th Annual International Congress in Paris, France. The studies were sponsored by Merz Pharmaceuticals, which plans to file a Biologic License Application (BLA) for NT-201 in the USA in the near future.
News of the day
Prostate Cancer Screening Has Yet To Prove Its Worth
The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians. Authored by Otis W. Brawley, M.D. of the American Cancer Society and Donna Ankerst, Ph.D. and Ian M. Thompson, M.D. of the University of Texas Health Science Center at San Antonio, the review says because prostate cancer is virtually ubiquitous in men as they age, it is clear that a goal of "finding more cancers" is not acceptable. Instead, public health principles demand that screening must reduce the risk of death from prostate cancer, reduce the suffering from prostate cancer, or reduce health care costs when compared with a non-screening scenario. The authors suggest prostate cancer screening has yet to reach one of these standards to date.
Cardiovascular

British Medical Association Comment On Announcement On NHS Treatment Centres

The Department of Health announced that the terms offered to independent providers of treatment centres in the NHS in England will in future be more similar to those offered to NHS providers. Commenting on the announcement, Dr Hamish Meldrum, Chairman of Council at the BMA, says: "Millions of pounds" worth of taxpayers" money has been wasted because of the government"s determination to encourage the private sector into our NHS. When the first wave of these contracts comes to an end next year, the majority of independent providers will have failed to deliver the amount of work they have been paid for. "It"s a shame it"s taken so long to get an acknowledgement that skewing the playing field in favour of private companies has been unfair and wasteful. Independent sector treatment centres have been able to cherry-pick "easier" cases, potentially destabilising existing services. Even in future, private companies will be at an advantage because when things go wrong with a patient"s care, it"s the NHS that picks up the tab. "Especially in the current climate, the NHS cannot afford poor value contracts, unnecessary competition, and duplication of services. We need much more of a whole-systems approach to the provision of healthcare, and we need the NHS to be run on the basis of co-operation collaboration, not competition." Notes 1) View a BMA briefing paper on ISTCs here. 2) The BMA is currently raising awareness of the implications of NHS market reforms through its "Look After Our NHS campaign": http://lookafterournhs.org.uk British Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):